Multicenter midterm follow-up results using the gore septal occluder for atrial septal defect closure in pediatric patients.

about

Transcatheter closure of atrial septal defect: principles and available devices

P2860

Q57300712-9BBDD97D-CCCE-4CE8-A9AC-AB93D9946831

P2860

Multicenter midterm follow-up results using the gore septal occluder for atrial septal defect closure in pediatric patients.

Item

http://www.wikidata.org/entity/Q39143686

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Multicenter midterm follow-up ...... closure in pediatric patients.

@en

Multicenter midterm follow-up ...... closure in pediatric patients.

@nl

type

Item

label

Multicenter midterm follow-up ...... closure in pediatric patients.

@en

Multicenter midterm follow-up ...... closure in pediatric patients.

@nl

prefLabel

Multicenter midterm follow-up ...... closure in pediatric patients.

@en

Multicenter midterm follow-up ...... closure in pediatric patients.

@nl

P1476

Multicenter midterm follow-up ...... closure in pediatric patients.

@en

P2093

Brigitte Stiller

http://www.w3.org/2001/XMLSchema#string

Christian Wildberg

http://www.w3.org/2001/XMLSchema#string

Christoph Kampmann

http://www.w3.org/2001/XMLSchema#string

Claudia Schmoor

http://www.w3.org/2001/XMLSchema#string

Erwin Kitzmüller

http://www.w3.org/2001/XMLSchema#string

Gleb Tarusinov

http://www.w3.org/2001/XMLSchema#string

Jochen Grohmann

http://www.w3.org/2001/XMLSchema#string

Tariq Abu-Tair

http://www.w3.org/2001/XMLSchema#string

P2860

Device closure of secundum atrial septal defect's and the risk of cardiac erosion

Combined prospective United States clinical study data for the GORE(®) HELEX(®) septal occluder device.

Critical overview of Nitinol surfaces and their modifications for medical applications.

Indications for cardiac catheterization and intervention in pediatric cardiac disease: a scientific statement from the American Heart Association.

Analysis of the US Food and Drug Administration Manufacturer and User Facility Device Experience database for adverse events involving Amplatzer septal occluder devices and comparison with the Society of Thoracic Surgery congenital cardiac surgery d

Self-expanding nitinol stents: material and design considerations.

Single center experience: Implantation failures, early, and late complications after implantation of a partially biodegradable ASD/PFO-device (BioStar®).

Erosion of Amplatzer septal occluder device after closure of secundum atrial septal defects: review of registry of complications and recommendations to minimize future risk.

Prosthetic vascular grafts: wrong models, wrong questions and no healing.

Late complete atrioventricular block after closure of an atrial septal defect with a gore septal occluder (GSO™).

P304

E226-E232

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CCD.26881

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Peter Zartner

P577

2016-11-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27900839

http://www.w3.org/2001/XMLSchema#string

Multicenter midterm follow-up results using the gore septal occluder for atrial septal defect closure in pediatric patients.

about

P2860

P2860

Multicenter midterm follow-up results using the gore septal occluder for atrial septal defect closure in pediatric patients.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698